Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7L1 pseudogene 13 (RPL7L1P13)
- Target
- RPL7L1P13
- Molecular classification
- Other (Pseudogene)
01
Overview
RPL7L1 pseudogene 13 (RPL7L1P13) is classified as a pseudogene, meaning it shares sequence homology with the gene encoding ribosomal protein L7-like 1 (RPL7L1) but is not believed to produce a functional protein. Pseudogenes like RPL7L1P13 are often remnants of gene duplication or retrotransposition events and typically lack biological function in terms of protein coding. There are no known associations with disease, biological activity, or drug targeting for RPL7L1P13. It is not considered a therapeutic target, has no established role in physiological or pathological processes, and does not interact with drugs[5][7].
- Other names
- Ribosomal protein L7-like 1 pseudogene 13
Beyond the preview
Go deeper on RPL7L1 pseudogene 13 (RPL7L1P13).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RPL7L1 pseudogene 13 (RPL7L1P13).